<DOC>
	<DOCNO>NCT02356965</DOCNO>
	<brief_summary>The purpose study test two different dos ketamine sub-lingual ( tongue ) wafer placebo see effective medication treat moderate severe pain wisdom tooth extraction .</brief_summary>
	<brief_title>Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction</brief_title>
	<detailed_description>This Phase 2 , randomize , double-blind , parallel group , dose-ranging placebo-controlled evaluation analgesic efficacy , safety pharmacokinetics ketamine sublingual wafer adult subject experience post-operative pain undergoing third molar extraction . The study enroll approximately 80 subject single site . Subjects least 18 year 38 year age . Subjects receive single dose 70 mg 100 mg sublingual ketamine wafer placebo . Efficacy assessment include pain intensity , use rescue medication , Patient Global Assessment ( PGA ) pain control . Safety assessment include monitor AEs SAEs , clinical laboratory test , vital sign measurement , oral assessment , ECGs . A maximum eight 4ml blood sample take participant 8 hour study drug administration plasma analysis .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy male female subject , age 1838 year old , schedule undergo two ipsilateral third molar extraction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Third molar extraction</keyword>
	<keyword>Wisdom tooth extraction</keyword>
</DOC>